Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts; Grayken Center for Addiction, Boston Medical Center, One Boston Medical Center Place, Boston, Massachusetts; Division of General Pediatrics, Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts.
The London School of Hygiene and Tropical Medicine, London, United Kingdom.
J Adolesc Health. 2023 Jan;72(1):105-110. doi: 10.1016/j.jadohealth.2022.08.026. Epub 2022 Oct 8.
Young adults with opioid use disorder (OUD) have low engagement in treatment with medication for opioid use disorder (MOUD). The objective of this study is to explore the beliefs and attitudes about MOUD among young adults.
We conducted a single-site qualitative study of 20 young adults ages 18-29 years with a diagnosis of OUD receiving care at an outpatient program and who spoke English. We used a flexible interview guide with the following domains: experience with MOUD, sources and impact of stigma, and interactions with family, healthcare professionals, and social networks. We conducted a thematic analysis based on deductive codes related to the domains and emergent codes from the interviews.
We identified three themes. First, participants perceived being on MOUD as stigmatizing. They regarded MOUD as lifesaving but ultimately as a "crutch" hindering their full recovery. Second, young adults expressed ambivalence, distinct from stigma, about MOUD. This ambivalence was related to fear of withdrawal symptoms and concerns about their ability to live independent lives, side effects, and unknown treatment duration. Third, participants felt that MOUD was more than just a means to reduce risk of overdose, it was a means to become fully functioning in their lives.
In this study of young adults in treatment for OUD, we found that stigma and ambivalence concerning MOUD could explain young adults' low engagement in care. Interventions addressing concerns about the stigmatizing effects of MOUD and the ambivalence young adults experience related to MOUD could improve engagement and retention of young adults.
患有阿片类药物使用障碍(OUD)的年轻人参与阿片类药物使用障碍药物治疗(MOUD)的比例较低。本研究的目的是探讨年轻人对 MOUD 的看法和态度。
我们对 20 名年龄在 18-29 岁之间、患有 OUD 并在门诊接受治疗的年轻人进行了一项单站点定性研究,这些年轻人会说英语。我们使用了一份灵活的访谈指南,其中包括以下领域:MOUD 的体验、污名的来源和影响,以及与家庭、医疗保健专业人员和社交网络的互动。我们根据与领域相关的演绎代码和访谈中的新兴代码进行了主题分析。
我们确定了三个主题。首先,参与者认为接受 MOUD 治疗具有污名化。他们认为 MOUD 可以救命,但最终它是一种阻碍他们完全康复的“拐杖”。其次,年轻人对 MOUD 表现出矛盾的态度,与污名化不同。这种矛盾态度与对戒断症状的恐惧以及对独立生活能力、副作用和未知治疗持续时间的担忧有关。第三,参与者认为 MOUD 不仅仅是减少过量风险的手段,它还是他们在生活中完全正常运作的手段。
在这项对接受 OUD 治疗的年轻人的研究中,我们发现,对 MOUD 的污名化和矛盾态度可以解释年轻人对治疗的低参与度。针对 MOUD 的污名化影响和年轻人对 MOUD 所经历的矛盾态度的干预措施,可能会提高年轻人的治疗参与度和保留率。